Emergent Biosolutions Email Format

Biotechnology Research
501-1,000 employees
Gaithersburg, MD, USA

Emergent Biosolutions is a biotechnology company that develops, manufactures, and delivers medical countermeasures and protections against public health threats worldwide.

Find contacts at Emergent Biosolutions

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

lastfirstinitial@ebsi.com

Company Overview

Industry
Biotechnology Research
Founded
1998
Headquarters
Gaithersburg, MD, USA
Revenue
$1B-$2.5B
FUNDING Stage
Public
Key Executives
Joseph C. Papa (President and Chief Executive Officer), Richard S. Lindahl (Executive Vice President, Chief Financial Officer), Howard Anderson (SVP & CIO)

Tech Stack

Akamai

Infrastructure

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Emergent Biosolutions?

Emergent Biosolutions uses the lastfirstinitial format on emergentbiosolutions.com, so Jane Smith would be smithj@emergentbiosolutions.com.

What are the two main business segments that Emergent Biosolutions operates across?

Emergent Biosolutions operates across two primary segments: Medical Countermeasures, which covers biodefense products like BioThrax, ACAM2000, TEMBEXA, and Ebanga for government stockpiles, and Opioid Emergency Preparedness, which includes NARCAN Nasal Spray and KLOXXADO for opioid overdose response.

How does Emergent Biosolutions supply products to the U.S. Strategic National Stockpile?

Emergent Biosolutions holds long-term supply contracts with U.S. government agencies including BARDA and the CDC to deliver medical countermeasures such as BioThrax anthrax vaccine and TEMBEXA smallpox antiviral directly to the Strategic National Stockpile.

Who is the CEO of Emergent Biosolutions?

Joseph C. Papa has served as President and Chief Executive Officer of Emergent Biosolutions since February 2024. He previously served as CEO and chairman of Bausch and Lomb Corporation, where he led the company's IPO.

Can Clay help me find a verified Emergent Biosolutions contact email?

Yes, Clay can enrich a list of Emergent Biosolutions contacts by verifying their emails against the confirmed lastfirstinitial format on ebsi.com, helping sales and recruiting teams reach the right people with accurate, deliverable addresses.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles